Social disadvantage associated with increased multimorbidity risk
Multimorbidity prevalence, defined as the co-occurrence of two or more co-existing chronic conditions within an individual, has been steadily rising…
Multimorbidity prevalence, defined as the co-occurrence of two or more co-existing chronic conditions within an individual, has been steadily rising…
At the 2026 American Heart Association (AHA) Scientific Sessions, research was presented that demonstrated encouraging results for the use of…
Novo Nordisk presented the study design and baseline patient characteristics of the ongoing Phase III ARTEMIS trial, evaluating ziltivekimab for…
At this year's American Heart Association (AHA) Scientific Sessions, positive Phase Ib results from a trial evaluating CRISPR Therapeutics' CTX310,…
At this year’s American Heart Association (AHA) conference, hosted in Chicago, Bayer presented a poster presentation featuring a sub-analysis of…
At this year's American Heart Association (AHA) Scientific Sessions, new findings evaluating the impact of concomitant glucagon-like peptide-1 receptor agonist…
At this year's American Heart Association (AHA) Scientific Sessions, primary results from the Phase III Lp(a) HORIZON trial evaluating Novartis'…
At this year's American Heart Association (AHA) scientific sessions, Phase IIb results from the TYDAL-TIMI 78 trial (NCT07028749) evaluating Marea…
A post hoc analysis of the Phase III ACHIEVE-3 trial shows that orforglipron 36mg delivered a greater reduction in predicted…
The buildup of scar tissue, also known as fibrosis, occurs in most chronic, inflammatory conditions and is implicated in nearly…